Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2021

  1. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

2019

  1. Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism

    Movement Disorders, Vol. 34, Núm. 10, pp. 1547-1561

  2. Reply to: “Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion”

    Movement Disorders

2004

  1. Levodopa in the treatment of Parkinson's disease: Current controversies

    Movement Disorders, Vol. 19, Núm. 9, pp. 997-1005

1999

  1. Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile

    Neurologia, Vol. 14, Núm. 7, pp. 338-343